The effect of AVP and DGAVP on the exploratory activity of rats.
The effects of [8-L-arginine] vasopressin (AVP) and desglycinamide [8-L-arginine] vasopressin (DGAVP) were tested on the exploratory activity of adult male rats in a novel environment. The inherited individual differences in the non-specific excitability level of the animals were ascertained prior to the drug administration and the rats were then distributed evenly into the experimental groups. One half of each groups contained the less excitable and the other the more excitable animals. The peptides or saline were injected every other day--altogether 4 times--in a dose of 5 micrograms/kg/ml subcutaneously, 40 min before starting the experiments. The exploratory activity in the novel environment was observed for 15 min. AVP and DGAVP, which differ in their peripheral endocrine activities, had opposite effects on the behavior in a novel environment: AVP, with its wide spectrum of peripheral effects, decreased the exploratory activity, whereas DGAVP, with minimal peripheral effects, increased the exploratory activity slightly. This basic response to the administration of peptides was influenced by the type of inherent non-specific excitability level. The depressive action of AVP was more pronounced in the more excitable rats, whereas DGAVP significantly stimulated the less excitable animals. It is concluded that the inhibitory effect of AVP is mainly due to its peripheral endocrine, especially hemodynamic, effects, whereas DGAVP is supposed to increase arousal, which is responsible for differences in the animals' performance with regard to their inherited non-specific excitability levels.
Skopková
J
J
Czechoslovak Academy of Sciences, Institute of Organic Chemistry and Biochemistry, Praha.
Lát
J
J
Dvorská
I
I
Hrbas
P
P
Radil
T
T
D000818:Animals; D001127:Arginine Vasopressin / Q000031:analogs & derivatives* / Q000494:pharmacology*; D005106:Exploratory Behavior / Q000187:drug effects*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
D001127:Arginine Vasopressin; C015119:argipressin, des-GlyNH2(9)-